The effect of oral alpha-lipoic acid on oxidative stress in adolescents with type 1 diabetes mellitus

Pediatric Diabetes

Volumn 9, Issue 3 PART 2, 2008, Pages 69-73

  Huang, Eric A ^a   Gitelman, Stephen E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Diabetes complications; Oxidative stress; Thioctic acid

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ALBUMIN; CREATININE; GLUCOTIZE; HEMOGLOBIN A1C; INSULIN ASPART; INSULIN GLARGINE; INSULIN LISPRO; ISOPHANE INSULIN; PLACEBO; THIOBARBITURIC ACID; THIOCTIC ACID;

ADOLESCENT; ALBUMIN BLOOD LEVEL; ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC NEUROPATHY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG ERUPTION; DRUG HYPERSENSITIVITY; FEMALE; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MICROALBUMINURIA; OXIDATION; OXIDATIVE STRESS; PATIENT COMPLIANCE; PILOT STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CARBONYLATION; PUBERTY; RANDOMIZED CONTROLLED TRIAL; URINALYSIS;

ADMINISTRATION, ORAL; ADOLESCENT; AGE OF ONSET; BODY MASS INDEX; BODY WEIGHT; CHILD; DELAYED-ACTION PREPARATIONS; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; MALE; OXIDATIVE STRESS; PLACEBOS; PUBERTY; REFERENCE VALUES; THIOBARBITURIC ACID REACTIVE SUBSTANCES; THIOCTIC ACID;

EID: 44849098170     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/j.1399-5448.2007.00342.x     Document Type: Article

References (32)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993: 329: 977-986.
2. Nathan DM, Cleary PA, Backlund JY et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005: 353: 2643-2653.
3. Saydah SH, Fradkin J, Cowie CC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA 2004: 291: 335-342.
4. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001: 414: 813-820.
5. Du XL, Edelstein D, Rossetti L et al. Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc Natl Acad Sci U S A 2000: 97: 12222-12226.
6. Nishikawa T, Edelstein D, Du XL et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000: 404: 787-790.
7. Dincer Y, Akcay T, Ilkova H, Alademir Z, Ozbay G. DNA damage and antioxidant defense in peripheral leukocytes of patients with type I diabetes mellitus. Mutat Res 2003: 527: 49-55.
8. Dominguez C. Ruiz E Gussinye M, Carrascosa A. Oxidative stress at onset and in early stages of type 1 diabetes in children and adolescents. Diabetes Care 1998: 21: 1736-1742.
9. Telci A, Cakatay U, Salman S, Satman I, Sivas A. Oxidative protein damage in early stage type 1 diabetic patients. Diabetes Res Clin Pract 2000: 50: 213-223.
10. Ziegler D, Nowak H, Kempler P, Vargha P, Low PA. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: A meta-analysis. Diabet Med 2004: 21: 114-121.
11. Evans JL, Heymann CJ, Goldfine ID, Gavin LA. Pharmacokinetics, tolerability, and fructosamine-lowering effect of a novel, controlled-release formulation of alpha-lipoic acid. Endocr Pract 2002: 8: 29-35.
12. Bogdanov M, Brown RH, Matson W et al. Increased oxidative damage to DNA in ALS patients. Free Radic Biol Med 2000: 29: 652-658.
13. Benzie IF. Lipid peroxidation: A review of causes, consequences, measurement and dietary influences. Int J Food Sci Nutr 1996: 47: 233-261.
14. Cakatay U. Protein oxidation parameters in type 2 diabetic patients with good and poor glycaemic control. Diabetes Metab 2005: 31: 551-557.
15. Mercuri F, Quagliaro L, Ceriello A. Oxidative stress evaluation in diabetes. Diabetes Technol Ther 2000: 2: 589-600.
16. Niculescu L, Stancu C, Sima A, Toporan D, Simionescu M. The total peroxyl radical trapping potential in serum - an assay to define the stage of atherosclerosis. J Cell Mol Med 2001: 5: 285-294.
17. Meskar A, Le Bras R, L'Emeillat M, Menez JF. Glycated haemoglobin: comparison between methods based upon 5-hydroxymethylfurfural determination (colorimetric or HPLC) and ion exchange chromatography (HbA1). J Clin Chem Clin Biochem 1985: 23: 197-202.
18. Buss IH, Winterbourn CC. Protein carbonyl measurement by ELISA. Methods Mol Biol 2002: 186: 123-128.
19. Park JW, Cundy KC, Ames BN. Detection of DNA adducts by high-performance liquid chromatography with electrochemical detection. Carcinogenesis 1989: 10: 827-832.
20. Wang JF, Schramm DD, Holt RR et al. A dose-response effect from chocolate consumption on plasma epicatechin and oxidative damage. J Nutr 2000: 130 (8S Suppl): 2115S-2119S.
21. Kato A, Odamaki M, Hishida A. Blood 8-hydroxy-2′-deoxyguanosine is associated with erythropoietin resistance in haemodialysis patients. Nephrol Dial Transplant 2003: 18: 931-936.
22. Bryden KS, Dunger DB, Mayou RA, Peveler RC. Neil HA. Poor prognosis of young adults with type 1 diabetes: A longitudinal study. Diabetes Care 2003: 26: 1052-1057.
23. Henricsson M, Nystrom L, Blohme G et al. The incidence of retinopathy 10 years after diagnosis in young adult people with diabetes: Results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS). Diabetes Care 2003: 26: 349-354.
24. Svensson M, Sundkvist G, Arnqvist HJ et al. Signs of nephropathy may occur early in young adults with diabetes despite modern diabetes management: Results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS). Diabetes Care 2003: 26: 2903-2909.
25. Soro-P aavonen A, Forbes JM. Novel therapeutics for diabetic micro- and macrovascular complications. Curr Med Chem 2006: 13: 1777-1788.
26. Gouty S, Regalia J, Cai F, Helke CJ. Alpha-lipoic acid treatment prevents the diabetes-induced attenuation of the afferent limb of the baroreceptor reflex in rats. Auton Neurosci 2003: 108: 32-44.
27. Melhem MF, Craven PA, Derubertis FR. Effects of dietary supplementation of alpha-lipoic acid on early glomerular injury in diabetes mellitus. J Am Soc Nephrol 2001: 12: 124-133.
28. Obrosova IG, Minchenko AG, Marinescu V et al. Antioxidants attenuate early up regulation of retinal vascular endothelial growth factor in streptozotocin-diabetic rats. Diabetologia 2001: 44: 1102-1110.
29. Siu B, Saha J, Smoyer WE, Sullivan KA, Brosius FC. Reduction in podocyte density as a pathologic feature in early diabetic nephropathy in rodents: Prevention by lipoic acid treatment. BMC Nephrol 2006: 7: 6.
30. Arguelles S, Garcia S, Maldonado M, Machado A, Ayala A. Do the serum oxidative stress biomarkers provide a reasonable index of the general oxidative stress status? Biochim Biophys Acta 2004: 1674: 251-259.
31. Cakatay U. Pro-oxidant actions of alpha-lipoic acid and dihydrolipoic acid. Med Hypotheses 2006: 66: 110-117.
32. Salvemini D, Wang ZQ, Zweier JL et al. A nonpeptidyl mimic of superoxide dismutase with therapeutic activity in rats. Science 1999: 286: 304-306.